These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23878932)

  • 21. Fluoroquinolone resistance in a clinical isolate of Streptococcus pneumoniae in the South Pacific.
    Le Hello S; Page S; Garin B
    Int J Antimicrob Agents; 2008 Jul; 32(1):91-2. PubMed ID: 18495439
    [No Abstract]   [Full Text] [Related]  

  • 22. mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway.
    Sangvik M; Littauer P; Simonsen GS; Sundsfjord A; Dahl KH
    J Antimicrob Chemother; 2005 Nov; 56(5):841-6. PubMed ID: 16172106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro.
    Anderson R; Steel HC; Cockeran R; von Gottberg A; de Gouveia L; Klugman KP; Mitchell TJ; Feldman C
    J Antimicrob Chemother; 2007 Nov; 60(5):1155-8. PubMed ID: 17848373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phage display-derived inhibitor of the essential cell wall biosynthesis enzyme MurF.
    Paradis-Bleau C; Lloyd A; Sanschagrin F; Clarke T; Blewett A; Bugg TD; Levesque RC
    BMC Biochem; 2008 Dec; 9():33. PubMed ID: 19099588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of MurF from Streptococcus pneumoniae co-crystallized with a small molecule inhibitor exhibits interdomain closure.
    Longenecker KL; Stamper GF; Hajduk PJ; Fry EH; Jakob CG; Harlan JE; Edalji R; Bartley DM; Walter KA; Solomon LR; Holzman TF; Gu YG; Lerner CG; Beutel BA; Stoll VS
    Protein Sci; 2005 Dec; 14(12):3039-47. PubMed ID: 16322581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and biochemical characterization of Mur ligases from Staphylococcus aureus.
    Patin D; Boniface A; Kovač A; Hervé M; Dementin S; Barreteau H; Mengin-Lecreulx D; Blanot D
    Biochimie; 2010 Dec; 92(12):1793-800. PubMed ID: 20659527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.
    Bley C; van der Linden M; Reinert RR
    Int J Antimicrob Agents; 2011 May; 37(5):425-31. PubMed ID: 21419605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulvinones as bacterial cell wall biosynthesis inhibitors.
    Antane S; Caufield CE; Hu W; Keeney D; Labthavikul P; Morris K; Naughton SM; Petersen PJ; Rasmussen BA; Singh G; Yang Y
    Bioorg Med Chem Lett; 2006 Jan; 16(1):176-80. PubMed ID: 16216496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial activity of DW-224a, a new fluoroquinolone, against Streptococcus pneumoniae.
    Kim HJ; Seol MJ; Park HS; Choi DR; Seong SK; Shin HK; Kwak JH
    J Antimicrob Chemother; 2006 Jun; 57(6):1256-8. PubMed ID: 16603643
    [No Abstract]   [Full Text] [Related]  

  • 30. Complex Formation between Mur Enzymes from
    Miyachiro MM; Granato D; Trindade DM; Ebel C; Paes Leme AF; Dessen A
    Biochemistry; 2019 Jul; 58(30):3314-3324. PubMed ID: 31264408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A proteomic analysis of erythromycin resistance in Streptococcus pneumoniae.
    Cash P; Argo E; Ford L; Lawrie L; McKenzie H
    Electrophoresis; 1999 Aug; 20(11):2259-68. PubMed ID: 10493130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital.
    Bonofiglio L; Ojeda MI; de Mier C; Vay C; Famiglietti A; Gutkind G; Mollerach M
    Int J Antimicrob Agents; 2005 Mar; 25(3):260-3. PubMed ID: 15737523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of tigecycline against Streptococcus pneumoniae, an important causative pathogen of community-acquired pneumonia (CAP).
    Hawser SP
    J Infect; 2010 Apr; 60(4):306-8. PubMed ID: 20144899
    [No Abstract]   [Full Text] [Related]  

  • 34. Activities of ceftobiprole and other beta-lactams against Streptococcus pneumoniae clinical isolates from the United States with defined substitutions in penicillin-binding proteins PBP 1a, PBP 2b, and PBP 2x.
    Davies TA; Shang W; Bush K
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2530-2. PubMed ID: 16801437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic analysis of the copper resistance of Streptococcus pneumoniae.
    Guo Z; Han J; Yang XY; Cao K; He K; Du G; Zeng G; Zhang L; Yu G; Sun Z; He QY; Sun X
    Metallomics; 2015 Mar; 7(3):448-54. PubMed ID: 25608595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro antibacterial activities of doripenem, imipenem, and meropenem against recent Streptococcus pneumoniae isolates.
    Baek JY; Ko KS; Kang CI; Song JH; Peck KR
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):297-300. PubMed ID: 21855246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel inhibitors of Streptococcus pneumoniae based on the virtual screening with the homology-modeled structure of histidine kinase (VicK).
    Li N; Wang F; Niu S; Cao J; Wu K; Li Y; Yin N; Zhang X; Zhu W; Yin Y
    BMC Microbiol; 2009 Jun; 9():129. PubMed ID: 19558698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic potential activity of quercetin complexes against Streptococcus pneumoniae.
    Osman ME; Abo-Elnasr AA; Mohamed ET
    Sci Rep; 2024 Jun; 14(1):12876. PubMed ID: 38834612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in pneumococcal peptidoglycan biosynthesis suggest new vaccine and antimicrobial targets.
    Sham LT; Tsui HC; Land AD; Barendt SM; Winkler ME
    Curr Opin Microbiol; 2012 Apr; 15(2):194-203. PubMed ID: 22280885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single amino acid substitution in the MurF UDP-MurNAc-pentapeptide synthetase renders Streptococcus pneumoniae dependent on CO2 and temperature.
    Burghout P; Quintero B; Bos L; Beilharz K; Veening JW; de Jonge MI; van der Linden M; van der Ende A; Hermans PW
    Mol Microbiol; 2013 Aug; 89(3):494-506. PubMed ID: 23750975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.